NO942376L - Terapeutiske midler - Google Patents

Terapeutiske midler

Info

Publication number
NO942376L
NO942376L NO942376A NO942376A NO942376L NO 942376 L NO942376 L NO 942376L NO 942376 A NO942376 A NO 942376A NO 942376 A NO942376 A NO 942376A NO 942376 L NO942376 L NO 942376L
Authority
NO
Norway
Prior art keywords
alkyl
represents hydrogen
halo
alkoxy
pct
Prior art date
Application number
NO942376A
Other languages
English (en)
Norwegian (no)
Other versions
NO942376D0 (fi
Inventor
Bernard John Armitage
John Gareth Bowen
Malcolm John Crossley
Ian Michael Hunneyball
Bruce William Leslie
Thomas Kerr Miller
Michael Spowage
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO942376D0 publication Critical patent/NO942376D0/no
Publication of NO942376L publication Critical patent/NO942376L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO942376A 1991-12-23 1994-06-22 Terapeutiske midler NO942376L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
PCT/EP1992/002901 WO1993013097A1 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (2)

Publication Number Publication Date
NO942376D0 NO942376D0 (fi) 1994-06-22
NO942376L true NO942376L (no) 1994-06-22

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942376A NO942376L (no) 1991-12-23 1994-06-22 Terapeutiske midler

Country Status (22)

Country Link
US (1) US5464781A (fi)
EP (1) EP0618916B1 (fi)
JP (1) JP2527917B2 (fi)
CN (1) CN1096784A (fi)
AT (1) ATE171452T1 (fi)
AU (1) AU656832B2 (fi)
BG (1) BG98813A (fi)
CA (1) CA2125858A1 (fi)
CZ (1) CZ153594A3 (fi)
DE (1) DE69227125T2 (fi)
FI (1) FI943019A (fi)
GB (1) GB9127252D0 (fi)
HR (1) HRP921455A2 (fi)
HU (1) HUT66971A (fi)
IL (1) IL104169A0 (fi)
IN (1) IN174405B (fi)
MX (1) MX9207494A (fi)
NO (1) NO942376L (fi)
NZ (1) NZ246156A (fi)
SI (1) SI9200408A (fi)
SK (1) SK75094A3 (fi)
WO (1) WO1993013097A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
US6809097B1 (en) * 1996-09-25 2004-10-26 Zeneca Limited Quinoline derivatives inhibiting the effect of growth factors such as VEGF
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
EP1192151B1 (en) 1999-07-09 2007-11-07 Glaxo Group Limited Anilinoquinazolines as protein tyrosine kinase inhibitors
BR0109828A (pt) 2000-04-07 2002-12-17 Astrazeneca Ab Composto, processo para a prepapação do mesmo ou de um sal deste, composição farmacêutica, uso do composto ou de um sal deste farmaceuticamente aceitável, e, método para a produção de um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente em necessidade de tal tratamento
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
US7618975B2 (en) 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
UA82577C2 (en) 2003-12-23 2008-04-25 Пфайзер Инк. Quinoline derivatives
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
ES2395386T3 (es) * 2005-12-21 2013-02-12 Abbott Laboratories Compuestos antivirales
TW200738707A (en) * 2005-12-21 2007-10-16 Abbott Lab Anti-viral compounds
AU2006330924B2 (en) * 2005-12-21 2012-03-15 Abbvie Inc. Anti-viral compounds
DE602006015861D1 (de) * 2005-12-21 2010-09-09 Abbott Lab Antivirale verbindungen
EP2345652A1 (en) 2005-12-21 2011-07-20 Abbott Laboratories Antiviral compounds
TWI399380B (zh) 2006-12-20 2013-06-21 Abbott Lab 抗病毒化合物
US20110269758A1 (en) * 2008-07-03 2011-11-03 Merck Patent Gmbh Naphthyridinones as protein kinase inhibitors
US8415333B2 (en) 2009-02-24 2013-04-09 Respiratorious Ab Bronchodilating diazaheteroaryls
US8853235B2 (en) * 2009-11-23 2014-10-07 Senhwa Biosciences, Inc. Polymorphs and salts of a kinase inhibitor
MY175079A (en) 2010-04-02 2020-06-04 Firmenich Incorporated Sweet flavor modifier

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
EP0222839A4 (en) * 1985-05-17 1988-11-09 Univ Australian ANTI-MALARIA COMPOUNDS.
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc ｐ−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
JPH07116187B2 (ja) * 1987-07-22 1995-12-13 シェリング・コーポレーション 二環式化合物、それらを薬剤として使用すること、それらの製法、およびそれらの製造に有用な中間体
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 １，８−ナフチリジン−２−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
AU3158793A (en) 1993-07-28
AU656832B2 (en) 1995-02-16
IL104169A0 (en) 1993-05-13
DE69227125T2 (de) 1999-02-18
BG98813A (bg) 1995-05-31
JP2527917B2 (ja) 1996-08-28
CZ153594A3 (en) 1995-02-15
SI9200408A (en) 1993-09-30
GB9127252D0 (en) 1992-02-19
CN1096784A (zh) 1994-12-28
CA2125858A1 (en) 1993-07-08
JPH07502280A (ja) 1995-03-09
EP0618916A1 (en) 1994-10-12
IN174405B (fi) 1994-11-26
HUT66971A (en) 1995-01-30
NO942376D0 (fi) 1994-06-22
SK75094A3 (en) 1995-04-12
HU9401877D0 (en) 1994-09-28
WO1993013097A1 (en) 1993-07-08
HRP921455A2 (en) 1994-12-31
DE69227125D1 (de) 1998-10-29
FI943019A0 (fi) 1994-06-22
FI943019A (fi) 1994-06-22
ATE171452T1 (de) 1998-10-15
NZ246156A (en) 1996-01-26
EP0618916B1 (en) 1998-09-23
US5464781A (en) 1995-11-07
MX9207494A (es) 1993-07-01

Similar Documents

Publication Publication Date Title
NO942376L (no) Terapeutiske midler
WO1993001165A3 (en) Aromatic compounds, compositions containing them and their use in therapy
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GR3034769T3 (en) Triazole antifungal agents.
ES2180564T3 (es) 2-fenil-3-azoilbenzotiofenos para aumentar la expresion de trombomodulina.
IL134894A (en) 2-substituted-1,3,4,5-tetrahydro-2h-gamma-carbolines, their preparation and pharmaceutical compositions containing them
GB9305641D0 (en) Therapeutic agents
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
FI943020A0 (fi) Terapeuttisia aineita
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
SE0102058D0 (sv) New Salts II
JO1754B1 (en) Therapeutic agents
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
ZA952403B (en) New 2,4-diphosphonoglutaric acid derivatives processes for their production and pharmaceutical agents containing these compounds
AR018002A1 (es) Composicion farmaceutica que comprende un anticonvulsivo y una resina de intercambio ionico para el tratamiento de la epilepsia, compuestos, uso de lapirrolidona polivinilica y proceso para preparar la composicion